Unlike the more common RET mutations found in medullary thyroid carcinoma (MTC) and MEN2, the most prevalent pro-carcinogenic variant of the RET gene in papillary thyroid carcinoma (PTC) is RET rearrangement [31]. This evidence concerns the gene RET and differentiated thyroid carcinoma.